Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

23rd Annual Needham Virtual Healthcare ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET Location: Virtual

Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing SummitFireside Chat: Monday, April 29, 2024 at 9:30 am ET Location: Virtual

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com

Grafico Azioni Vor Biopharma (NASDAQ:VOR)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Vor Biopharma
Grafico Azioni Vor Biopharma (NASDAQ:VOR)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Vor Biopharma